Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Lisa Pleyer & Richard Greil. (2015) Digging deep into “dirty” drugs – modulation of the methylation machinery. Drug Metabolism Reviews 47:2, pages 252-279.
Read now
Read now
Articles from other publishers (13)
Rachael Nicholson, Ana Catarina Menezes, Aleksandra Azevedo, Adam Leckenby, Sara Davies, Claire Seedhouse, Amanda Gilkes, Steve Knapper, Alex Tonks & Richard L. Darley. (2022) Protein Kinase C Epsilon Overexpression Is Associated With Poor Patient Outcomes in AML and Promotes Daunorubicin Resistance Through p-Glycoprotein-Mediated Drug Efflux. Frontiers in Oncology 12.
Crossref
Crossref
Jian Zhang, Yuhui Peng, Yan He, Yan Xiao, Qinrong Wang, Yan Zhao, Tin Zhang, Changxue Wu, Yuan Xie, Jianjiang Zhou, Wenfeng Yu, Deqin Lu, Hua Bai, Tenxiang Chen, Penxiang Guo & Qifang Zhang. (2022) GPX1-associated prognostic signature predicts poor survival in patients with acute myeloid leukemia and involves in immunosuppression. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1868:1, pages 166268.
Crossref
Crossref
Paola Fernanda Ruiz-Aparicio, Natalia-Del Pilar Vanegas, Gloria Inés Uribe, Paola Ortiz-Montero, Camila Cadavid-Cortés, Jimmy Lagos, Jessica Flechas-Afanador, Adriana Linares-Ballesteros & Jean-Paul Vernot. (2020) Dual Targeting of Stromal Cell Support and Leukemic Cell Growth by a Peptidic PKC Inhibitor Shows Effectiveness against B-ALL. International Journal of Molecular Sciences 21:10, pages 3705.
Crossref
Crossref
Genevieve Tyndale Clutton & R. Brad Jones. (2018) Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure. Frontiers in Immunology 9.
Crossref
Crossref
Madhumita Roy, Ruma Sarkar, Apurba Mukherjee & Sutapa Mukherjee. (2015) Inhibition of crosstalk between Bcr-Abl and PKC signaling by PEITC, augments imatinib sensitivity in chronic myelogenous leukemia cells. Chemico-Biological Interactions 242, pages 195-201.
Crossref
Crossref
Peter P. Ruvolo, Liran Zhou, Julie C. Watt, Vivian R. Ruvolo, Jared K. Burks, Tilahun Jiffar, Steven Kornblau, Marina Konopleva & Michael Andreeff. (2011) Targeting PKC-mediated signal transduction pathways using enzastaurin to promote apoptosis in acute myeloid leukemia-derived cell lines and blast cells. Journal of Cellular Biochemistry 112:6, pages 1696-1707.
Crossref
Crossref
Matthew R. Janes & David A. Fruman. (2010) Targeting TOR dependence in cancer. Oncotarget 1:1, pages 69-76.
Crossref
Crossref
S-F Wu, Y Huang, J-K Hou, T-T Yuan, C-X Zhou, J Zhang & G-Q Chen. (2010) The downregulation of onzin expression by PKCɛ-ERK2 signaling and its potential role in AML cell differentiation. Leukemia 24:3, pages 544-551.
Crossref
Crossref
Efstratios Katsoulidis, Surinder Kaur & Leonidas C. Platanias. (2010) Deregulation of Interferon Signaling in Malignant Cells. Pharmaceuticals 3:2, pages 406-418.
Crossref
Crossref
Elisabeth Ersvaer, Astrid Olsnes Kittang, Peter Hampson, Kristoffer Sand, Bjørn Tore Gjertsen, Janet M. Lord & Øystein Bruserud. (2010) The Protein Kinase C Agonist PEP005 (Ingenol 3-Angelate) in the Treatment of Human Cancer: A Balance between Efficacy and Toxicity. Toxins 2:1, pages 174-194.
Crossref
Crossref
Vivian R. Ruvolo, Kul B. Karanjeet, Todd F. Schuster, Rhoderick Brown, Yibin Deng, Edward Hinchcliffe & Peter P. Ruvolo. (2010) Role for PKC in Fenretinide-Mediated Apoptosis in Lymphoid Leukemia Cells. Journal of Signal Transduction 2010, pages 1-15.
Crossref
Crossref
Thomas Efferth. 2010. Nitric Oxide (NO) and Cancer. Nitric Oxide (NO) and Cancer
265
282
.
Amanda J. Redig, Antonella Sassano, Beata Majchrzak-Kita, Efstratios Katsoulidis, Hui Liu, Jessica K. Altman, Eleanor N. Fish, Amittha Wickrema & Leonidas C. Platanias. (2009) Activation of Protein Kinase C? by Type I Interferons. Journal of Biological Chemistry 284:16, pages 10301-10314.
Crossref
Crossref